Angel Enrique
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Angel Enrique has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Derek Richards
School of Psychology, Trinity College Dublin, Dublin, Ireland
24 shared publications - Daniel Duffy
SilverCloud Science SilverCloud Health Dublin Ireland
13 shared publications - Jorge Palacios
Bright Therapeutics, San Francisco, CA, United States
10 shared publications - Ladislav Timulak
Trinity College Dublin
8 shared publications - Cristina Botella
Department of Basic, Clinical Psychology and Psychobiology, Universitat Jaume I, Castellón, Spain; CIBER de Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain
7 shared publications - Guadalupe Molinari
International University of Valencia, Valencia, Spain
6 shared publications
Latest Publications
- 22 October 2026
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- p. 1-17
Effectiveness of the internet-based unified protocol transdiagnostic intervention for the treatment of depression, anxiety, and related disorders in a routine primary care setting in Ireland: a pilot pragmatic randomized controlled trial
- 22 October 2026
- Published by Taylor & Francis in Cognitive Behaviour Therapy
- p. 1-17
Effectiveness of the internet-based unified protocol transdiagnostic intervention for the treatment of depression, anxiety, and related disorders in a routine primary care setting in Ireland: a pilot pragmatic randomized controlled trial
- 1 May 2026
- Published by Grupo Editorial Psicofundación in Apuntes de Psicología
- Vol. 44 (2) , 69-76
Implementación del Paradigma de Salud Mental de Precisión en Entornos Reales: Presentación del Proyecto NOVA
RESUMEN A pesar de que la Práctica Basada en la Evidencia (PBE) ha estandarizado los tratamientos psicológicos, la realidad clínica sigue enfrentándose a una barrera persistente: la dificultad de traducir los resultados de ensayos clínicos grupales a la singularidad de cada paciente en contextos reales. Como respuesta, la Salud Mental de Precisión (SMP) propone una evolución del modelo actual, integrando el cuidado basado en la medición y la toma de decisiones basada en datos para ajustar la intervención a las necesidades específicas de cada persona, gracias en gran medida a desarrollos tecnológicos recientes como la Inteligencia Artificial (IA). En este contexto, el presente artículo persigue dos objetivos fundamentales. En primer lugar, sintetiza los pilares operativos de la SMP, analizando cómo la medición rutinaria y las predicciones algorítmicas pueden potenciar el juicio clínico del profesional. En segundo lugar, se introduce el proyecto NOVA (Navigating Outcomes via Analytics), un proyecto traslacional diseñado para superar las barreras actitudinales, tecnológicas, estadísticas y contextuales de la implementación de herramientas de SMP en España. Se discute sobre los pasos necesarios para cerrar la brecha entre la innovación tecnológica y la práctica asistencial en psicología, acelerando la adopción sostenible de una psicología de precisión en el mundo real.
- 1 May 2026
- Published by Grupo Editorial Psicofundación in Apuntes de Psicología
- Vol. 44 (2) , 69-76
Implementación del Paradigma de Salud Mental de Precisión en Entornos Reales: Presentación del Proyecto NOVA
RESUMEN A pesar de que la Práctica Basada en la Evidencia (PBE) ha estandarizado los tratamientos psicológicos, la realidad clínica sigue enfrentándose a una barrera persistente: la dificultad de traducir los resultados de ensayos clínicos grupales a la singularidad de cada paciente en contextos reales. Como respuesta, la Salud Mental de Precisión (SMP) propone una evolución del modelo actual, integrando el cuidado basado en la medición y la toma de decisiones basada en datos para ajustar la intervención a las necesidades específicas de cada persona, gracias en gran medida a desarrollos tecnológicos recientes como la Inteligencia Artificial (IA). En este contexto, el presente artículo persigue dos objetivos fundamentales. En primer lugar, sintetiza los pilares operativos de la SMP, analizando cómo la medición rutinaria y las predicciones algorítmicas pueden potenciar el juicio clínico del profesional. En segundo lugar, se introduce el proyecto NOVA (Navigating Outcomes via Analytics), un proyecto traslacional diseñado para superar las barreras actitudinales, tecnológicas, estadísticas y contextuales de la implementación de herramientas de SMP en España. Se discute sobre los pasos necesarios para cerrar la brecha entre la innovación tecnológica y la práctica asistencial en psicología, acelerando la adopción sostenible de una psicología de precisión en el mundo real.
- Open Access
- 7 April 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e80689
Changes in Workplace Productivity and Estimated Cost Savings During Internet-Based Cognitive Behavioral Therapy in the Irish National Health Service: Naturalistic, Repeated-Measures, Retrospective Survey Study
Background: Depression and anxiety can significantly impact workplace productivity, for instance, by increasing absenteeism and presenteeism. This loss of productivity leads to diminished workplace economic outcomes. Internet-based cognitive behavioral therapy (iCBT) has emerged as a cost-effective intervention within workplace settings that improves workplace productivity loss due to depression and anxiety, but more generalizable evidence beyond the workplace, such as in a national health service setting, is lacking. Objective: This naturalistic, repeated-measures, retrospective study investigated the impact of iCBT on work productivity metrics using nationally representative data from patients enrolled in the Irish national health service (ie, the Health Service Executive). Methods: We analyzed repeated measures retrospective data from 7125 employed patients enrolled in iCBT at the Health Service Executive between March 2023 and May 2024. The Work Productivity and Activity Impairment questionnaire was used to measure absenteeism, presenteeism, overall productivity loss, and activity impairment. Secondary outcomes included depression (Patient Health Questionnaire-9) and anxiety (Generalized Anxiety Disorder-7). Patients were primarily 25 to 64 years old (n=5578, 78%), female (n=4956, 70%), and met clinical scoring criteria on the Patient Health Questionnaire-9 or Generalized Anxiety Disorder-7 (n=4774, 67%). Missing data were handled using multiple imputation. We used mixed-effects models to assess pre-post treatment changes in outcomes and then utilized Irish national salary estimates from 2022 to derive cost savings (in 2022 € values; €1=approximately US $1.05) based on productivity improvement during use of the iCBT program. Results: From baseline to follow-up, absenteeism reduced by 6.85% ( P <.001, 95% CI 5.79%‐7.91%, Cohen d =0.21), presenteeism reduced by 5.84% ( P <.001, 95% CI 4.59%‐7.09%, Cohen d =0.18), productivity loss reduced by 9.48% ( P <.001, 95% CI 8.30%‐10.66%, Cohen d =0.27), and activity impairment reduced by 8.34% ( P <.001, 95% CI 7.07%‐9.61%, Cohen d =0.30). Depression symptom scores reduced by 2.70 points ( P <.001, 95% CI 2.50‐2.90, Cohen d =0.51) and anxiety symptom scores reduced by 2.71 points ( P <.001, 95% CI 2.51‐2.91, Cohen d =0.52) scores posttreatment. Larger reductions in depression and anxiety symptoms were linked to greater improvements in workplace functioning outcomes ( r =0.06-0.34, all P <.001). Patients with higher baseline clinical severity experienced approximately 6% greater improvements in workplace productivity than subclinical patients ( P <.001). These improvements in work productivity from baseline to follow-up corresponded to more than €4000 annual savings per patient treated, which equated to an estimated annual savings of €29 million in the sample (in 2022 € values). The average currency exchange rate in 2022 would be €1 to approximately US $1.05. Conclusions: Building on work that primarily focused on work productivity improvements from iCBT in occupational contexts, this study provides evidence that iCBT for the general adult population in a national routine health care setting is associated with improvements in both Common mental disorders (CMD) and workplace productivity losses associated with CMD. These productivity improvements were further associated with sizable cost savings. These findings suggest that integrating iCBT into national mental health infrastructure can be a feasible, scalable solution, which could generate clinical and economic benefits at a population level.
- 7 April 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e80689
Open AccessChanges in Workplace Productivity and Estimated Cost Savings During Internet-Based Cognitive Behavioral Therapy in the Irish National Health Service: Naturalistic, Repeated-Measures, Retrospective Survey Study
Background: Depression and anxiety can significantly impact workplace productivity, for instance, by increasing absenteeism and presenteeism. This loss of productivity leads to diminished workplace economic outcomes. Internet-based cognitive behavioral therapy (iCBT) has emerged as a cost-effective intervention within workplace settings that improves workplace productivity loss due to depression and anxiety, but more generalizable evidence beyond the workplace, such as in a national health service setting, is lacking. Objective: This naturalistic, repeated-measures, retrospective study investigated the impact of iCBT on work productivity metrics using nationally representative data from patients enrolled in the Irish national health service (ie, the Health Service Executive). Methods: We analyzed repeated measures retrospective data from 7125 employed patients enrolled in iCBT at the Health Service Executive between March 2023 and May 2024. The Work Productivity and Activity Impairment questionnaire was used to measure absenteeism, presenteeism, overall productivity loss, and activity impairment. Secondary outcomes included depression (Patient Health Questionnaire-9) and anxiety (Generalized Anxiety Disorder-7). Patients were primarily 25 to 64 years old (n=5578, 78%), female (n=4956, 70%), and met clinical scoring criteria on the Patient Health Questionnaire-9 or Generalized Anxiety Disorder-7 (n=4774, 67%). Missing data were handled using multiple imputation. We used mixed-effects models to assess pre-post treatment changes in outcomes and then utilized Irish national salary estimates from 2022 to derive cost savings (in 2022 € values; €1=approximately US $1.05) based on productivity improvement during use of the iCBT program. Results: From baseline to follow-up, absenteeism reduced by 6.85% ( P <.001, 95% CI 5.79%‐7.91%, Cohen d =0.21), presenteeism reduced by 5.84% ( P <.001, 95% CI 4.59%‐7.09%, Cohen d =0.18), productivity loss reduced by 9.48% ( P <.001, 95% CI 8.30%‐10.66%, Cohen d =0.27), and activity impairment reduced by 8.34% ( P <.001, 95% CI 7.07%‐9.61%, Cohen d =0.30). Depression symptom scores reduced by 2.70 points ( P <.001, 95% CI 2.50‐2.90, Cohen d =0.51) and anxiety symptom scores reduced by 2.71 points ( P <.001, 95% CI 2.51‐2.91, Cohen d =0.52) scores posttreatment. Larger reductions in depression and anxiety symptoms were linked to greater improvements in workplace functioning outcomes ( r =0.06-0.34, all P <.001). Patients with higher baseline clinical severity experienced approximately 6% greater improvements in workplace productivity than subclinical patients ( P <.001). These improvements in work productivity from baseline to follow-up corresponded to more than €4000 annual savings per patient treated, which equated to an estimated annual savings of €29 million in the sample (in 2022 € values). The average currency exchange rate in 2022 would be €1 to approximately US $1.05. Conclusions: Building on work that primarily focused on work productivity improvements from iCBT in occupational contexts, this study provides evidence that iCBT for the general adult population in a national routine health care setting is associated with improvements in both Common mental disorders (CMD) and workplace productivity losses associated with CMD. These productivity improvements were further associated with sizable cost savings. These findings suggest that integrating iCBT into national mental health infrastructure can be a feasible, scalable solution, which could generate clinical and economic benefits at a population level.
- Open Access
- 16 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Impact of internet-based cognitive behavioural therapy on workplace functioning: Evidence from a real-world national evaluation (Preprint)
BACKGROUND Depression and anxiety significantly impact labour participation and productivity, leading to adverse health and economic outcomes at a population level. Internet-based Cognitive Behavioural Therapy (iCBT) has emerged as a cost-effective intervention within workplace settings, but more generalisable evidence is lacking. OBJECTIVE This naturalistic, observational study investigated the impact of iCBT on work-related outcomes using nationally representative data from patients enrolled in routine care in Ireland. METHODS We analysed retrospective data from N=7125 patients enrolled in iCBT through the Irish national health service between March 2023-May 2024. The Work Productivity and Activity Impairment (WPAI) questionnaire was used to measure absenteeism, presenteeism, overall productivity loss, and activity impairment. Secondary outcomes included depression (Patient Health Questionnaire-9) and anxiety (Generalised Anxiety Disorder-7). We used mixed-effects models to assess pre-post treatment changes in outcomes, and estimated cost-savings from productivity improvement using Irish median salary data. RESULTS Overall, patients showed significant improvements in all WPAI outcomes with small effect sizes (6-9%, d=.18-30). Greater improvements in workplace functioning were linked to larger reductions in depression (r=.10-.34) and anxiety symptoms (r=.06-.33), both of which on average reduced by ~3 points. Patients with higher baseline clinical severity experienced more substantial improvements in workplace functioning than subclinical patients. These productivity gains correspond to >€4000 annual savings per patient treated, totalling to over €29 million for our nationally representative sample. CONCLUSIONS Our findings support iCBT as a scalable, cost-effective intervention that can effectively improve workplace functioning by attenuating symptoms of depression and anxiety when integrated within public health service provision
- 16 July 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImpact of internet-based cognitive behavioural therapy on workplace functioning: Evidence from a real-world national evaluation (Preprint)
BACKGROUND Depression and anxiety significantly impact labour participation and productivity, leading to adverse health and economic outcomes at a population level. Internet-based Cognitive Behavioural Therapy (iCBT) has emerged as a cost-effective intervention within workplace settings, but more generalisable evidence is lacking. OBJECTIVE This naturalistic, observational study investigated the impact of iCBT on work-related outcomes using nationally representative data from patients enrolled in routine care in Ireland. METHODS We analysed retrospective data from N=7125 patients enrolled in iCBT through the Irish national health service between March 2023-May 2024. The Work Productivity and Activity Impairment (WPAI) questionnaire was used to measure absenteeism, presenteeism, overall productivity loss, and activity impairment. Secondary outcomes included depression (Patient Health Questionnaire-9) and anxiety (Generalised Anxiety Disorder-7). We used mixed-effects models to assess pre-post treatment changes in outcomes, and estimated cost-savings from productivity improvement using Irish median salary data. RESULTS Overall, patients showed significant improvements in all WPAI outcomes with small effect sizes (6-9%, d=.18-30). Greater improvements in workplace functioning were linked to larger reductions in depression (r=.10-.34) and anxiety symptoms (r=.06-.33), both of which on average reduced by ~3 points. Patients with higher baseline clinical severity experienced more substantial improvements in workplace functioning than subclinical patients. These productivity gains correspond to >€4000 annual savings per patient treated, totalling to over €29 million for our nationally representative sample. CONCLUSIONS Our findings support iCBT as a scalable, cost-effective intervention that can effectively improve workplace functioning by attenuating symptoms of depression and anxiety when integrated within public health service provision
- Open Access
- 26 March 2025
- Published by Center for Open Science in PsyArXiv
Impact of internet-based cognitive behavioural therapy on workplace functioning: Evidence from a real-world national evaluation
Introduction. Depression and anxiety significantly impact labour participation and productivity, leading to adverse health and economic outcomes at a population level. Internet-based Cognitive Behavioural Therapy (iCBT) has emerged as a cost-effective intervention within workplace settings, but more generalisable evidence is lacking. This naturalistic, observational study investigated the impact of iCBT on work-related outcomes using nationally representative data from patients enrolled in routine care in Ireland. Methods. We analysed retrospective data from N=7125 patients enrolled in iCBT through the Irish national health service between March 2023-May 2024. The Work Productivity and Activity Impairment (WPAI) questionnaire was used to measure absenteeism, presenteeism, overall productivity loss, and activity impairment. Secondary outcomes included depression (Patient Health Questionnaire-9) and anxiety (Generalised Anxiety Disorder-7). We used mixed-effects models to assess pre-post treatment changes in outcomes, and estimated cost-savings from productivity improvement using Irish median salary data. Results. Overall, patients showed significant improvements in all WPAI outcomes with small effect sizes (6-9%, d=.18-30). Greater improvements in workplace functioning were linked to larger reductions in depression (r=.10-.34) and anxiety symptoms (r=.06-.33), both of which on average reduced by ~3 points. Patients with higher baseline clinical severity experienced more substantial improvements in workplace functioning than subclinical patients. These productivity gains correspond to >€4000 annual savings per patient treated, totalling to over €29 million for our nationally representative sample. Conclusion. Our findings support iCBT as a scalable, cost-effective intervention that can effectively improve workplace functioning associated with depression and anxiety when integrated within public health service provision.
- 26 March 2025
- Published by Center for Open Science in PsyArXiv
Open AccessImpact of internet-based cognitive behavioural therapy on workplace functioning: Evidence from a real-world national evaluation
Introduction. Depression and anxiety significantly impact labour participation and productivity, leading to adverse health and economic outcomes at a population level. Internet-based Cognitive Behavioural Therapy (iCBT) has emerged as a cost-effective intervention within workplace settings, but more generalisable evidence is lacking. This naturalistic, observational study investigated the impact of iCBT on work-related outcomes using nationally representative data from patients enrolled in routine care in Ireland. Methods. We analysed retrospective data from N=7125 patients enrolled in iCBT through the Irish national health service between March 2023-May 2024. The Work Productivity and Activity Impairment (WPAI) questionnaire was used to measure absenteeism, presenteeism, overall productivity loss, and activity impairment. Secondary outcomes included depression (Patient Health Questionnaire-9) and anxiety (Generalised Anxiety Disorder-7). We used mixed-effects models to assess pre-post treatment changes in outcomes, and estimated cost-savings from productivity improvement using Irish median salary data. Results. Overall, patients showed significant improvements in all WPAI outcomes with small effect sizes (6-9%, d=.18-30). Greater improvements in workplace functioning were linked to larger reductions in depression (r=.10-.34) and anxiety symptoms (r=.06-.33), both of which on average reduced by ~3 points. Patients with higher baseline clinical severity experienced more substantial improvements in workplace functioning than subclinical patients. These productivity gains correspond to >€4000 annual savings per patient treated, totalling to over €29 million for our nationally representative sample. Conclusion. Our findings support iCBT as a scalable, cost-effective intervention that can effectively improve workplace functioning associated with depression and anxiety when integrated within public health service provision.
- Top Cited PapersOpen Access
- 5 February 2024
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computer-Human Interaction
- Vol. 31 (2) , 1-59
Between Rhetoric and Reality: Real-world Barriers to Uptake and Early Engagement in Digital Mental Health Interventions
Digital mental health interventions (DMHIs) have potential to provide effective and accessible care to entire populations, but low client uptake and engagement are significant problems. Few prior studies explore the lived experiences of non-engagers, because reaching this population is inherently difficult. We present an observational inquiry into the barriers to sign-up and early use of a DMHI, along with reasons for initial interest in the DMHI. We collected 205 online questionnaire responses and 20 interviews from self-referring participants across four healthcare ecosystems in the UK and US. Questionnaire results revealed that uncertainty about DMHI usefulness and usability were the main barriers to uptake, whereas forgetting about it, not finding time for it and not finding it useful were the main barriers to early engagement. Participants reported multiple reasons for considering the DMHI, reflecting the contextual, subjective nature of mental health. Our thematic analysis generated themes around (1) the need for human connection, (2) the impact of self-stigma on help-seeking, (3) the lack of knowledge around DMHIs and psychological therapy, (4) the desire for personally relevant care, and (5) the fluctuating, perennial nature of mental health. We discuss implications for DMHI design, implementation and future research, as well as transdisciplinary opportunities.
- 5 February 2024
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computer-Human Interaction
- Vol. 31 (2) , 1-59
Top Cited PapersOpen AccessBetween Rhetoric and Reality: Real-world Barriers to Uptake and Early Engagement in Digital Mental Health Interventions
Digital mental health interventions (DMHIs) have potential to provide effective and accessible care to entire populations, but low client uptake and engagement are significant problems. Few prior studies explore the lived experiences of non-engagers, because reaching this population is inherently difficult. We present an observational inquiry into the barriers to sign-up and early use of a DMHI, along with reasons for initial interest in the DMHI. We collected 205 online questionnaire responses and 20 interviews from self-referring participants across four healthcare ecosystems in the UK and US. Questionnaire results revealed that uncertainty about DMHI usefulness and usability were the main barriers to uptake, whereas forgetting about it, not finding time for it and not finding it useful were the main barriers to early engagement. Participants reported multiple reasons for considering the DMHI, reflecting the contextual, subjective nature of mental health. Our thematic analysis generated themes around (1) the need for human connection, (2) the impact of self-stigma on help-seeking, (3) the lack of knowledge around DMHIs and psychological therapy, (4) the desire for personally relevant care, and (5) the fluctuating, perennial nature of mental health. We discuss implications for DMHI design, implementation and future research, as well as transdisciplinary opportunities.
- Open Access
- 29 November 2023
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computer-Human Interaction
- Vol. 31 (1) , 1-50
Patient Acceptance of Self-Monitoring on a Smartwatch in a Routine Digital Therapy: A Mixed-Methods Study
Self-monitoring of mood and lifestyle habits is the cornerstone of many therapies, but it is still hindered by persistent issues including inaccurate records, gaps in the monitoring, patient burden, and perceived stigma. Smartwatches have the potential to deliver enhanced self-reports, but their acceptance in clinical mental health settings is unexplored and rendered difficult by a complex theoretical landscape and need for a longitudinal perspective. We present the Mood Monitor smartwatch application for mood and lifestyle habits self-monitoring. We investigated patient acceptance of the app within a routine 8-week digital therapy. We recruited 35 patients of the UK’s National Health Service and evaluated their acceptance through three online questionnaires and a post-study interview. We assessed the clinical feasibility of the Mood Monitor by comparing clinical, usage, and acceptance metrics obtained from the 35 patients with a smartwatch with those from an additional 34 patients without a smartwatch (digital treatment as usual). Findings showed that the smartwatch app was highly accepted by patients, revealed which factors facilitated and impeded this acceptance, and supported clinical feasibility. We provide guidelines for the design of self-monitoring on a smartwatch and reflect on the conduct of human-computer interaction research evaluating user acceptance of mental health technologies.
- 29 November 2023
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computer-Human Interaction
- Vol. 31 (1) , 1-50
Open AccessPatient Acceptance of Self-Monitoring on a Smartwatch in a Routine Digital Therapy: A Mixed-Methods Study
Self-monitoring of mood and lifestyle habits is the cornerstone of many therapies, but it is still hindered by persistent issues including inaccurate records, gaps in the monitoring, patient burden, and perceived stigma. Smartwatches have the potential to deliver enhanced self-reports, but their acceptance in clinical mental health settings is unexplored and rendered difficult by a complex theoretical landscape and need for a longitudinal perspective. We present the Mood Monitor smartwatch application for mood and lifestyle habits self-monitoring. We investigated patient acceptance of the app within a routine 8-week digital therapy. We recruited 35 patients of the UK’s National Health Service and evaluated their acceptance through three online questionnaires and a post-study interview. We assessed the clinical feasibility of the Mood Monitor by comparing clinical, usage, and acceptance metrics obtained from the 35 patients with a smartwatch with those from an additional 34 patients without a smartwatch (digital treatment as usual). Findings showed that the smartwatch app was highly accepted by patients, revealed which factors facilitated and impeded this acceptance, and supported clinical feasibility. We provide guidelines for the design of self-monitoring on a smartwatch and reflect on the conduct of human-computer interaction research evaluating user acceptance of mental health technologies.
- Open Access
- 12 July 2023
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 11 (1) , e41815
Trajectories of Symptoms in Digital Interventions for Depression and Anxiety Using Routine Outcome Monitoring Data: Secondary Analysis Study
Background: Research suggests there is heterogeneity in treatment response for internet-delivered cognitive behavioral therapy (iCBT) users, but few studies have investigated the trajectory of individual symptom change across iCBT treatment. Large patient data sets using routine outcome measures allows the investigation of treatment effects over time as well as the relationship between outcomes and platform use. Understanding trajectories of symptom change, as well as associated characteristics, may prove important for tailoring interventions or identifying patients who may not benefit from the intervention. Objective: We aimed to identify latent trajectories of symptom change during the iCBT treatment course for depression and anxiety and to investigate the patients’ characteristics and platform use for each of these classes. Methods: This is a secondary analysis of data from a randomized controlled trial designed to examine the effectiveness of guided iCBT for anxiety and depression in the UK Improving Access to Psychological Therapies (IAPT) program. This study included patients from the intervention group (N=256) and followed a longitudinal retrospective design. As part of the IAPT’s routine outcome monitoring system, patients were prompted to complete the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) after each supporter review during the treatment period. Latent class growth analysis was used to identify the underlying trajectories of symptom change across the treatment period for both depression and anxiety. Differences in patient characteristics were then evaluated between these trajectory classes, and the presence of a time-varying relationship between platform use and trajectory classes was investigated. Results: Five-class models were identified as optimal for both PHQ-9 and GAD-7. Around two-thirds (PHQ-9: 155/221, 70.1%; GAD-7: 156/221, 70.6%) of the sample formed various trajectories of improvement classes that differed in baseline score, the pace of symptom change, and final clinical outcome score. The remaining patients were in 2 smaller groups: one that saw minimal to no gains and another with consistently high scores across the treatment journey. Baseline severity, medication status, and program assigned were significantly associated (P<.001) with different trajectories. Although we did not find a time-varying relationship between use and trajectory classes, we found an overall effect of time on platform use, suggesting that all participants used the intervention significantly more in the first 4 weeks (P<.001). Conclusions: Most patients benefit from treatment, and the various patterns of improvement have implications for how the iCBT intervention is delivered. Identifying predictors of nonresponse or early response might inform the level of support and monitoring required for different types of patients. Further work is necessary to explore the differences between these trajectories to understand what works best for whom and to identify early on those patients who are less likely to benefit from treatment.
- 12 July 2023
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 11 (1) , e41815
Open AccessTrajectories of Symptoms in Digital Interventions for Depression and Anxiety Using Routine Outcome Monitoring Data: Secondary Analysis Study
Background: Research suggests there is heterogeneity in treatment response for internet-delivered cognitive behavioral therapy (iCBT) users, but few studies have investigated the trajectory of individual symptom change across iCBT treatment. Large patient data sets using routine outcome measures allows the investigation of treatment effects over time as well as the relationship between outcomes and platform use. Understanding trajectories of symptom change, as well as associated characteristics, may prove important for tailoring interventions or identifying patients who may not benefit from the intervention. Objective: We aimed to identify latent trajectories of symptom change during the iCBT treatment course for depression and anxiety and to investigate the patients’ characteristics and platform use for each of these classes. Methods: This is a secondary analysis of data from a randomized controlled trial designed to examine the effectiveness of guided iCBT for anxiety and depression in the UK Improving Access to Psychological Therapies (IAPT) program. This study included patients from the intervention group (N=256) and followed a longitudinal retrospective design. As part of the IAPT’s routine outcome monitoring system, patients were prompted to complete the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) after each supporter review during the treatment period. Latent class growth analysis was used to identify the underlying trajectories of symptom change across the treatment period for both depression and anxiety. Differences in patient characteristics were then evaluated between these trajectory classes, and the presence of a time-varying relationship between platform use and trajectory classes was investigated. Results: Five-class models were identified as optimal for both PHQ-9 and GAD-7. Around two-thirds (PHQ-9: 155/221, 70.1%; GAD-7: 156/221, 70.6%) of the sample formed various trajectories of improvement classes that differed in baseline score, the pace of symptom change, and final clinical outcome score. The remaining patients were in 2 smaller groups: one that saw minimal to no gains and another with consistently high scores across the treatment journey. Baseline severity, medication status, and program assigned were significantly associated (P<.001) with different trajectories. Although we did not find a time-varying relationship between use and trajectory classes, we found an overall effect of time on platform use, suggesting that all participants used the intervention significantly more in the first 4 weeks (P<.001). Conclusions: Most patients benefit from treatment, and the various patterns of improvement have implications for how the iCBT intervention is delivered. Identifying predictors of nonresponse or early response might inform the level of support and monitoring required for different types of patients. Further work is necessary to explore the differences between these trajectories to understand what works best for whom and to identify early on those patients who are less likely to benefit from treatment.
- Open Access
- 24 November 2022
- Published by Wiley in British Journal of Psychology
- Vol. 114 (2) , 299-314
Comparison of outcomes across low‐intensity psychological interventions for depression and anxiety within a stepped‐care setting: A naturalistic cohort study using propensity score modelling
Low‐intensity interventions for common mental disorders (CMD) address issues such as clinician shortages and barriers to accessing care. However, there is a lack of research into their comparative effectiveness in routine care. We aimed to compare treatment effects of three such interventions, utilizing four years' worth of routine clinical data. Users completing a course of guided self‐help bibliotherapy (GSH), internet‐delivered cognitive behavioural therapy (iCBT) or psychoeducational group therapy (PGT) from a stepped‐care service within the NHS in England were included. Propensity score models (stratification and weighting) were used to control for allocation bias and determine average treatment effect (ATE) between the interventions. 21,215 users comprised the study sample (GSH = 12,896, iCBT = 6862, PGT = 1457). Adherence‐to‐treatment rates were higher in iCBT. All interventions showed significant improvements in depression (PHQ‐9), anxiety (GAD‐7) and functioning (WSAS) scores, with largest effect sizes for iCBT. Both propensity score models showed a significant ATE in favour of iCBT versus GSH and PGT, and in favour of GSH versus PGT. Discernible differences in effectiveness were seen for iCBT in comparison with GSH and PGT. Given variance in delivery mode and human resources between different low‐intensity interventions, building on these findings would be valuable for future service provision and policy decision making.
- 24 November 2022
- Published by Wiley in British Journal of Psychology
- Vol. 114 (2) , 299-314
Open AccessComparison of outcomes across low‐intensity psychological interventions for depression and anxiety within a stepped‐care setting: A naturalistic cohort study using propensity score modelling
Low‐intensity interventions for common mental disorders (CMD) address issues such as clinician shortages and barriers to accessing care. However, there is a lack of research into their comparative effectiveness in routine care. We aimed to compare treatment effects of three such interventions, utilizing four years' worth of routine clinical data. Users completing a course of guided self‐help bibliotherapy (GSH), internet‐delivered cognitive behavioural therapy (iCBT) or psychoeducational group therapy (PGT) from a stepped‐care service within the NHS in England were included. Propensity score models (stratification and weighting) were used to control for allocation bias and determine average treatment effect (ATE) between the interventions. 21,215 users comprised the study sample (GSH = 12,896, iCBT = 6862, PGT = 1457). Adherence‐to‐treatment rates were higher in iCBT. All interventions showed significant improvements in depression (PHQ‐9), anxiety (GAD‐7) and functioning (WSAS) scores, with largest effect sizes for iCBT. Both propensity score models showed a significant ATE in favour of iCBT versus GSH and PGT, and in favour of GSH versus PGT. Discernible differences in effectiveness were seen for iCBT in comparison with GSH and PGT. Given variance in delivery mode and human resources between different low‐intensity interventions, building on these findings would be valuable for future service provision and policy decision making.
- Open Access
- 9 August 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Trajectories of Symptoms in Digital Interventions for Depression and Anxiety Using Routine Outcome Monitoring Data: Secondary Analysis Study (Preprint)
BACKGROUND Research suggests there is heterogeneity in treatment response for internet-delivered cognitive behavioral therapy (iCBT) users, but few studies have investigated the trajectory of individual symptom change across iCBT treatment. Large patient data sets using routine outcome measures allows the investigation of treatment effects over time as well as the relationship between outcomes and platform use. Understanding trajectories of symptom change, as well as associated characteristics, may prove important for tailoring interventions or identifying patients who may not benefit from the intervention. OBJECTIVE We aimed to identify latent trajectories of symptom change during the iCBT treatment course for depression and anxiety and to investigate the patients’ characteristics and platform use for each of these classes. METHODS This is a secondary analysis of data from a randomized controlled trial designed to examine the effectiveness of guided iCBT for anxiety and depression in the UK Improving Access to Psychological Therapies (IAPT) program. This study included patients from the intervention group (N=256) and followed a longitudinal retrospective design. As part of the IAPT’s routine outcome monitoring system, patients were prompted to complete the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) after each supporter review during the treatment period. Latent class growth analysis was used to identify the underlying trajectories of symptom change across the treatment period for both depression and anxiety. Differences in patient characteristics were then evaluated between these trajectory classes, and the presence of a time-varying relationship between platform use and trajectory classes was investigated. RESULTS Five-class models were identified as optimal for both PHQ-9 and GAD-7. Around two-thirds (PHQ-9: 155/221, 70.1%; GAD-7: 156/221, 70.6%) of the sample formed various trajectories of improvement classes that differed in baseline score, the pace of symptom change, and final clinical outcome score. The remaining patients were in 2 smaller groups: one that saw minimal to no gains and another with consistently high scores across the treatment journey. Baseline severity, medication status, and program assigned were significantly associated (P<.001) with different trajectories. Although we did not find a time-varying relationship between use and trajectory classes, we found an overall effect of time on platform use, suggesting that all participants used the intervention significantly more in the first 4 weeks (P<.001). CONCLUSIONS Most patients benefit from treatment, and the various patterns of improvement have implications for how the iCBT intervention is delivered. Identifying predictors of nonresponse or early response might inform the level of support and monitoring required for different types of patients. Further work is necessary to explore the differences between these trajectories to understand what works best for whom and to identify early on those patients who are less likely to benefit from treatment.
- 9 August 2022
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessTrajectories of Symptoms in Digital Interventions for Depression and Anxiety Using Routine Outcome Monitoring Data: Secondary Analysis Study (Preprint)
BACKGROUND Research suggests there is heterogeneity in treatment response for internet-delivered cognitive behavioral therapy (iCBT) users, but few studies have investigated the trajectory of individual symptom change across iCBT treatment. Large patient data sets using routine outcome measures allows the investigation of treatment effects over time as well as the relationship between outcomes and platform use. Understanding trajectories of symptom change, as well as associated characteristics, may prove important for tailoring interventions or identifying patients who may not benefit from the intervention. OBJECTIVE We aimed to identify latent trajectories of symptom change during the iCBT treatment course for depression and anxiety and to investigate the patients’ characteristics and platform use for each of these classes. METHODS This is a secondary analysis of data from a randomized controlled trial designed to examine the effectiveness of guided iCBT for anxiety and depression in the UK Improving Access to Psychological Therapies (IAPT) program. This study included patients from the intervention group (N=256) and followed a longitudinal retrospective design. As part of the IAPT’s routine outcome monitoring system, patients were prompted to complete the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) after each supporter review during the treatment period. Latent class growth analysis was used to identify the underlying trajectories of symptom change across the treatment period for both depression and anxiety. Differences in patient characteristics were then evaluated between these trajectory classes, and the presence of a time-varying relationship between platform use and trajectory classes was investigated. RESULTS Five-class models were identified as optimal for both PHQ-9 and GAD-7. Around two-thirds (PHQ-9: 155/221, 70.1%; GAD-7: 156/221, 70.6%) of the sample formed various trajectories of improvement classes that differed in baseline score, the pace of symptom change, and final clinical outcome score. The remaining patients were in 2 smaller groups: one that saw minimal to no gains and another with consistently high scores across the treatment journey. Baseline severity, medication status, and program assigned were significantly associated (P<.001) with different trajectories. Although we did not find a time-varying relationship between use and trajectory classes, we found an overall effect of time on platform use, suggesting that all participants used the intervention significantly more in the first 4 weeks (P<.001). CONCLUSIONS Most patients benefit from treatment, and the various patterns of improvement have implications for how the iCBT intervention is delivered. Identifying predictors of nonresponse or early response might inform the level of support and monitoring required for different types of patients. Further work is necessary to explore the differences between these trajectories to understand what works best for whom and to identify early on those patients who are less likely to benefit from treatment.